Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
Hims & Hers Health, Inc. (NYSE: HIMS) has appointed Kåre Schultz to its Board of Directors. Schultz brings extensive experience from his leadership roles at Novo Nordisk, Teva Pharmaceutical Industries, and Lundbeck. His expertise in the healthcare and pharmaceutical industries is expected to help Hims & Hers increase access to health and wellness solutions.
CEO Andrew Dudum highlighted Schultz's valuable perspective as the company aims to combine clinical excellence, healthcare, and technology. Schultz expressed enthusiasm for Hims & Hers' potential to transform healthcare by leveraging modern tools to improve access to health solutions. He joins a diverse board that includes leaders from various industries, such as former Cleveland Clinic CEO Dr. Toby Cosgrove and former Netflix CFO David Wells.
Hims & Hers Health, Inc. (NYSE: HIMS) ha nominato Kåre Schultz nel suo Consiglio di Amministrazione. Schultz porta con sé una vasta esperienza grazie ai suoi ruoli di leadership in Novo Nordisk, Teva Pharmaceutical Industries e Lundbeck. La sua competenza nelle industrie sanitaria e farmaceutica è attesa per aiutare Hims & Hers ad aumentare l'accesso a soluzioni per la salute e il benessere.
Il CEO Andrew Dudum ha evidenziato la preziosa prospettiva di Schultz mentre l'azienda punta a combinare eccellenza clinica, assistenza sanitaria e tecnologia. Schultz ha espresso entusiasmo per il potenziale di Hims & Hers di trasformare il settore sanitario sfruttando strumenti moderni per migliorare l'accesso alle soluzioni per la salute. Si unisce a un consiglio diversificato che include leader di vari settori, come l'ex CEO della Cleveland Clinic Dr. Toby Cosgrove e l'ex CFO di Netflix David Wells.
Hims & Hers Health, Inc. (NYSE: HIMS) ha nombrado a Kåre Schultz en su Junta Directiva. Schultz aporta una amplia experiencia de sus roles de liderazgo en Novo Nordisk, Teva Pharmaceutical Industries y Lundbeck. Se espera que su experiencia en las industrias de salud y farmacéutica ayude a Hims & Hers a aumentar el acceso a soluciones de salud y bienestar.
El CEO Andrew Dudum destacó la valiosa perspectiva de Schultz mientras la empresa busca combinar la excelencia clínica, la atención médica y la tecnología. Schultz expresó su entusiasmo por el potencial de Hims & Hers para transformar la atención médica aprovechando herramientas modernas para mejorar el acceso a soluciones de salud. Se une a una junta diversa que incluye a líderes de diversas industrias, como el ex-CEO de Cleveland Clinic, Dr. Toby Cosgrove, y el ex-CFO de Netflix, David Wells.
Hims & Hers Health, Inc. (NYSE: HIMS)는 Kåre Schultz를 이사회에 임명했습니다. Schultz는 Novo Nordisk, Teva Pharmaceutical Industries, Lundbeck에서의 리더십 경험이 풍부합니다. 건강 및 제약 산업에 대한 그의 전문성은 Hims & Hers가 건강과 웰빙 솔루션에 대한 접근성을 높이는 데 도움을 줄 것으로 기대됩니다.
CEO Andrew Dudum은 회사가 임상적 우수성, 건강 관리 및 기술을 결합하고자 할 때 Schultz의 소중한 관점을 강조했습니다. Schultz는 현대 도구를 활용하여 건강 솔루션에 대한 접근성을 향상시킬 수 있는 Hims & Hers의 잠재력에 대해 열정을 표명했습니다. 그는 이전 Cleveland Clinic CEO인 Dr. Toby Cosgrove와 이전 Netflix CFO인 David Wells와 같은 다양한 산업의 리더들이 포함된 다양성 높은 이사회에 합류하게 됩니다.
Hims & Hers Health, Inc. (NYSE: HIMS) a nommé Kåre Schultz au sein de son Conseil d'Administration. Schultz apporte une vaste expérience de ses fonctions de direction chez Novo Nordisk, Teva Pharmaceutical Industries et Lundbeck. Son expertise dans les secteurs de la santé et de la pharmacie devrait aider Hims & Hers à accroître l'accès aux solutions de santé et de bien-être.
Le PDG Andrew Dudum a souligné la précieuse perspective de Schultz alors que l'entreprise vise à allier excellence clinique, soins de santé et technologie. Schultz a exprimé son enthousiasme pour le potentiel de Hims & Hers à transformer les soins de santé en tirant parti d'outils modernes pour améliorer l'accès aux solutions de santé. Il rejoint un conseil diversifié qui comprend des leaders de différents secteurs, tels que l'ancien PDG de la Cleveland Clinic, Dr. Toby Cosgrove, et l'ancien CFO de Netflix, David Wells.
Hims & Hers Health, Inc. (NYSE: HIMS) hat Kåre Schultz in seinen Vorstand berufen. Schultz bringt umfassende Erfahrung aus seinen Führungspositionen bei Novo Nordisk, Teva Pharmaceutical Industries und Lundbeck mit. Seine Expertise in den Bereichen Gesundheitswesen und Pharmazie wird voraussichtlich Hims & Hers helfen, den Zugang zu Gesundheits- und Wellnesslösungen zu erweitern.
CEO Andrew Dudum hob die wertvolle Perspektive von Schultz hervor, während das Unternehmen anstrebt, klinische Exzellenz, Gesundheitsversorgung und Technologie zu kombinieren. Schultz äußerte seine Begeisterung für das Potenzial von Hims & Hers, das Gesundheitswesen durch den Einsatz moderner Werkzeuge zu transformieren, um den Zugang zu Gesundheitslösungen zu verbessern. Er tritt einem vielfältigen Vorstand bei, der Führungskräfte aus verschiedenen Branchen umfasst, darunter der ehemalige CEO der Cleveland Clinic, Dr. Toby Cosgrove, und der ehemalige CFO von Netflix, David Wells.
- Appointment of Kåre Schultz, an experienced pharmaceutical industry leader, to the Board of Directors
- Potential for improved strategic guidance in healthcare and pharmaceutical sectors
- Diverse board composition with expertise from various industries
- None.
Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions
Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions. (Photo: Business Wire)
Kåre Schultz brings a unique global perspective on the healthcare and pharmaceutical industries from his decades of leadership experience at several international organizations, including Teva Pharmaceutical Industries, Lundbeck, and Novo Nordisk. Mr. Schultz spent over 25 years at Novo Nordisk, where he served in many capacities, most notably as President and COO as the company established itself as a leading company in diabetes care. As CEO of Teva Pharmaceutical Industries, Mr. Schultz streamlined operations to focus the company on its core strengths in generics and specialty medicines. Mr. Schultz also served as CEO of Lundbeck, where he helped position the company as a leader in the pharmaceutical industry.
“We are in a transformative moment for healthcare with the opportunity to make life-changing treatments accessible to all who need it. Kåre’s experience gives us an incredible wealth of expertise as we bring together the most valuable elements of clinical excellence, healthcare, and technology to redefine health and wellness for our customers,” said Andrew Dudum, CEO and co-founder of Hims & Hers. “We’re honored to have Kåre join us to share his perspective and leadership as we continue to serve more customers across our platform.”
“Hims & Hers is on a trajectory to upend the healthcare industry,” said Kåre Schultz. “In my long career in the pharmaceutical industry, this is the first company I have seen that is leveraging today’s modern tools to truly break down barriers and change the status quo of how people access the health solutions they need to live their fullest lives. I’m thrilled to be a part of this journey.”
Mr. Schultz joins leaders from across industries on the Hims & Hers Board of Directors including: former CEO of the Cleveland Clinic, Dr. Toby Cosgrove; tech industry leader, Christopher Payne; US regulatory and foreign policy expert, Anja Manuel; former Chief Medical Officer of Walgreens and current Chief Medical Officer of Hims & Hers, Patrick Carroll; former CFO of Netflix, David Wells; consumer retail expert, Christiane Pendarvis; and former Nike and Sony marketing executive, Andrea Perez.
About Hims & Hers Health, Inc
Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalized care designed for results. For more information, please visit www.hims.com and www.forhers.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240722754740/en/
Press Contact
Abby Reisinger
press@forhims.com
Source: Hims & Hers
FAQ
Who is the new board member appointed to Hims & Hers (NYSE: HIMS)?
What experience does Kåre Schultz bring to Hims & Hers (NYSE: HIMS)?
How might Kåre Schultz's appointment impact Hims & Hers (NYSE: HIMS) business strategy?
Who are some other notable members of the Hims & Hers (NYSE: HIMS) Board of Directors?
